Takeda (TAK) CEO Julie So-Young Kim Sells 89,090 Shares

What Happened Julie So-Young Kim, President & CEO and a director of Takeda Pharmaceutical Co. (TAK), disposed of 89,090 shares on 2026-08-10 in an open-market/private sale. The filing reports a weighted average sale price of $17.10 per share for total proceeds of $1,523,439. The filing indicates this was a mandatory sale to cover taxes related to the vesting of equity awards.

Key Details

• Transaction date: 2026-08-10; Form 4 filed 2026-08-12.
• Transaction type: Sale (S) — 89,090 shares disposed.
• Reported weighted average price: $17.10; total proceeds: $1,523,439.
• Footnote F1: Mandatory sale to cover taxes on vested awards (tax-withholding).
• Footnote F2: $17.10 is a weighted average price; the reporting person can provide a breakdown of shares sold at each price on request.
• Shares owned after the transaction: Not disclosed in the provided filing.

Context This was a tax-withholding sale tied to vested equity rather than an independent open-market investment decision. Such mandatory withholding sales are common for executives receiving equity compensation and are generally considered routine administrative transactions rather than directional insider bets.